Skip to main content
. 2017 Apr 18;2017(4):CD012226. doi: 10.1002/14651858.CD012226.pub2

NCT02386722.

Trial name or title Intervention to Improve Inhalative Adherence
Methods Single‐blind, parallel‐group randomised controlled trial
Participants
  • Inpatients and outpatients older than 18 years with a clinical diagnosis of asthma or COPD

  • At least 1 exacerbation in the past year

  • Ability to give informed consent.

  • Good knowledge of the German language by themselves

  • Use of a metered dose Inhaler (e.g. Ventolin®), Diskus (e.g.Seretide®), Turbohaler (e.g.Symbicort®), Aerolizer/Breezhaler (e.g. Onbrez®) or HandiHaler (e.g. Spiriva®)

Interventions Audio reminders and support calls or control
Outcomes Time to next asthma or COPD exacerbation; number of exacerbations; adherence
Starting date January 2014
Contact information  
Notes https://clinicaltrials.gov/ct2/show/NCT02386722